Pronova, Teva Agree to Dismiss Patent Litigation in U.S.

Pronova BioPharma ASA and Teva Pharmaceuticals USA Inc. agreed to dismiss the patent litigation in the U.S. District Court for the District of Delaware pertaining to Pronova’s U.S. Patent No. 7,732,488, entitled “Pharmaceutical Composition Comprising Low Concentrations of Environmental Pollutants”, U.S. Patent No. 7,678,930, entitled “Process for Decreasing the Amount of Cholesterol in a Marine Oil Using a Volatile Working Fluid”, and U.S. Patent No. 7,718,698, entitled “Process for Decreasing Environmental Pollutants in an Oil or a Fat”.

To contact the editor responsible for this story: Meera Bhatia at mbhatia2@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.